• Advised on compliance with various government laws and regulations for multinational/domestic pharmaceutical, medical device, IT and tech companies.
• Advised on the establishment of compliance systems/SOP for multinational/domestic pharmaceutical, medical device, IT and tech companies.
• Advised on conducting internal investigations/third party audits for multinational/domestic pharmaceutical, medical device, IT and tech companies.
• Advised on various agreements, including license/co-promotion/distribution agreements for multinational/domestic pharmaceutical, medical device, IT and tech companies.
• Advised on local integration following a global M&A for multinational pharmaceutical and medical device companies.
• Advised on the establishment of a subsidiary/business restructuring for multinational pharmaceutical and medical device companies.
• Advised on M&A transactions for domestic pharmaceutical, medical device, food and cosmetics companies (e.g., share acquisition, business transfer, joint venture establishment, etc.) of multinational/domestic companies and PEF.
• Advised on responding to criminal proceedings, government investigations, litigations, and disputes for multinational/domestic pharmaceutical and medical device companies.
• Advised on HR/labor/tax/customs related issues for multinational pharmaceutical, medical device, IT and tech companies.
• Advised on compliance with various government laws and regulations for multinational liquor, tobacco, food and cosmetics companies.
• Advised on compliance with various government laws and regulations for multinational liquor, tobacco, food and cosmetics companies.
• Advised on compliance with various government laws and regulations for multinational/domestic industrials and consumer goods companies.

• Represented a Global 500 pharmaceutical company in a criminal proceeding/KFTC investigation related to fair trade (collusion; not guilty verdict, significantly lower administrative fine), and advised on overall compliance measures.
• Represented a Fortune 500 IT company in a criminal proceeding related to administrative regulations (energy regulation; no referral decision), and advised on regulatory compliance.
• Represented a Fortune 500 medical device company in a KFTC investigation related to fair trade (unfair solicitation; no violation decision), and advised on fair trade compliance.
• Represented a domestic engineering company in a World Bank audit, and advised on the establishment of an internal compliance system.
• Represented a multinational medical device company in a criminal proceeding/dispute, and advised on overall compliance measures.
• Advised a Fortune 500 healthcare company on responding to a customs audit (FX regulation) and regulatory compliance.
• Advised a mid-sized domestic company on conducting an internal investigation into employees’ unlawful conduct and advised on overall compliance measures.
• Advised a multinational tobacco company on restructuring and HR compliance.
• Advised a domestic beverage company on conducting an internal investigation into employees’ misconduct and overall compliance measures.
• Represented a Global 500 liquor company in a KFTC investigation related to fair trade (unfair business practice; no violation decision), and advised on fair trade compliance.
• Advised a Global 500 pharmaceutical company on fair trade compliance due diligence and improvement measures.
• Represented a multinational consulting services company in an external expert investigation under the External Audit Act (accounting fraud), and advised on overall compliance measures.
• Represented a multinational medical device company in a Financial Supervisory Service investigation related to administrative regulations (FX regulation; no criminal referral).
• Represented a Global 500 Tech company in a criminal proceeding/investigation related to administrative regulations (medical device regulation; no referral decision), and advised on overall compliance measures.
• Represented a multinational medical device company in a criminal proceeding related to customs (price manipulation; not guilty verdict), and advised on overall compliance measures.
• Represented a Fortune 500 semiconductor company in a criminal proceeding related to customs (fraudulent importation; summary order with a significantly lower fine), and advised on trade compliance measures.
• Advised a multinational liquor company on responding to a tax audit (liquor regulation; substantial reduction of tax amount) and regulatory compliance measures.
• Advised a Global 500 pharmaceutical company on regulatory compliance due diligence and improvement measures.
• Advised a Global 500 pharmaceutical company on conducting an internal investigation related to fair trade and compliance measures.
• Advised a multinational medical device company on responding to a tax audit (TP adjustment; no suspicion and substantial reduction of tax amount) and tax compliance measures.
• Represented a multinational cosmetic company in a recall procedure (chemical regulation; no criminal referral), and advised on regulatory compliance.
• Represented a multinational tobacco company in a criminal proceeding/dispute related to HR/labor (unjust labor practice; non-indictment decision), and advised on overall compliance measures.
• Represented a multinational liquor company in a KFTC investigation related to fair trade (unfair solicitation; no criminal referral, significantly lower administrative fine), and advised on fair trade compliance.
• Represented a Fortune 500 logistics company in a criminal proceeding related to administrative regulations (chemical regulation).
• Represented a multinational medical device company in a criminal proceeding/investigation related to administrative regulations (pharmaceutical regulation; no referral decision, revocation of disposition).
• Represented a multinational medical device company in an investigation related to administrative regulations (medical device regulation; no criminal referral), and advised on regulatory compliance.
• Advised a domestic construction company on responding to an external audit for overseas investments and reviewing compliance with the FCPA.
• Advised a multinational cosmetic company on overall compliance due diligence and improvement measures.
• Advised a global hedge fund on conducting an internal investigation into misconduct by domestic employees and agencies.
• Represented a multinational medical device company in a KFTC investigation related to fair trade (unfair solicitation; closing of examination procedure), and advised on fair trade compliance.
• Represented a multinational cosmetic company in a criminal proceeding related to customs (fraudulent importation; closing of investigation), and advised on regulatory compliance.
• Advised a domestic medical device company on establishing an internal compliance system.
• Represented a Global 500 pharmaceutical company in a criminal proceeding related to administrative regulations (chemical regulation; non-indictment decision for individual), and advised on regulatory compliance.
• Represented employees of a multinational medical device company in a white-collar criminal proceeding (fraud; non-indictment decision).
• Advised a multinational medical device company on conducting an investigation of workplace harassment and compliance measures.
• Represented a Global 500 pharmaceutical company in a civil lawsuit (product liability; successful defense).
• Represented a Fortune 500 veterinary drug company in a criminal proceeding/dispute related to HR/labor (unfair labor practices; non-indictment decision) and advised on overall compliance measures.
• Advised a multinational cosmetics company on conducting an internal investigation related to fair trade and compliance measures.
• Advised affiliates of a domestic steel company group on establishing an internal compliance system.
• Represented a multinational aerospace company in a criminal proceeding/dispute related to an aviation accident (negligence; non-indictment decision), and advised on overall compliance measures.
• Represented a domestic pharmaceutical distributor in a criminal proceeding related to administrative regulations (price regulation; non-indictment decision for corporation), and advised on regulatory compliance.
• Advised a multinational semiconductor company on conducting an internal investigation into employees’ misconduct and compliance measures.
• Advised a domestic medical device company on responding to a tax audit (rebate regulation; no criminal referral).
• Advised a multinational medical device company on establishing an internal compliance system.
• Advised a Global 500 pharmaceutical company on conducting an internal investigation related to fair trade and compliance measures.

Awards

  

• Best Lawyer, The JoongAng Lawyer Evaluation: Compliance·ESG (The JoongAng and Korea In-house Counsel Association, 2024)

  

Publications/Activities

• Main Speaker, “Domestic and International New Rebate Cases and Recent Compliance Issues in the Medical Device Industry,” Ethics Committee Regular Workshop (Korea Medical Device Industry Association, 2024)
• Main Speaker, “Compliance Issues Related to Patient Organizations and Patient Support Programs,” Ethical Management Workshop (Korea Pharmaceutical and Bio-Pharma Manufacturers Association, 2024)
• Moderator, “Practical Guide on the Implementation and Utilization of In-House AI Systems,” Joint Seminar with Microsoft (Kim & Chang, 2024)
• Main Speaker, “The Boundary Between Medical and Promotional Activities: Considerations from a Compliance Perspective,” Ethical Management Workshop (Korean Research-based Pharma Industry Association, 2023)
• Panel Speaker, “Corporate Investigations in Korea: Key Issues and Recent Trends,” Compliance Seminar (Kim & Chang Singapore Office, 2023)
• Main Speaker, “Risk Management Related to Major Financial Incidents in Companies,” Compliance Webinar (Kim & Chang, 2022)
• Main Speaker, “Recent Issues in Corporate Compliance-Focusing on Social Changes Due to the COVID-19 Pandemic,” KICA Webinar (Korean In-House Counsel Association, 2020)
• Panelist, “Internal Investigation Workshop,” Asia-Pacific Annual Meeting (Hong Kong Association of Corporate Counsel (ACC), 2019)
• A Study on Regulations Regarding the Admission and Establishment of Foreign Direct Investment (Master’s Dissertation, Seoul National University, 2012)